STOPPFrail Deprescribing Framework — SCE Palliative Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Systematic medication review using a framework such as STOPPFrail — identifying medications that are no longer providing net benefit given the patient's prognosis and goals
Explanation lettering: B = shown as A · A = shown as B · D = shown as C · C = shown as D
STOPPFrail is a validated tool specifically designed for older adults with frailty and limited life expectancy to guide deprescribing in palliative contexts. It has high inter-rater reliability and does not compromise clinical outcomes (e.g., quality of life, mortality) while reducing inappropriate polypharmacy ([medicinesresources.nhs.uk](https://www.medicinesresources.nhs.uk/en/Medicines-Awareness/Primary-Research/Randomised-controlled-trials/Deprescribing-in-Older-People-Approaching-End-of-Life-A-Randomized-Controlled-Trial-Using-STOPPFrail-Criteria/?utm_source=openai)). STOPPFrail has been utilised within pharmacist-led interventions in the UK to successfully reduce potentially inappropriate medications in frail elderly populations ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/40863706/?utm_source=openai)). Option B ignores the risks of continued polypharmacy; C is unsafe without individual assessment; D contradicts evidence demonstrating deprescribing safety; and E introduces an irrelevant cost-centric and unethical approach.
Reference: NHS UKMi summary of an RCT: Deprescribing in Older People Approaching End of Life using STOPPFrail Criteria (2026) and Pharmacist‑Led Interventions using STOPPFrail in the UK (2025), https://www.medicinesresources.nhs.uk/en/Medicines-Awareness/Primary-Research/Randomised-controlled-trials/Deprescribing-in-Older-People-Approaching-End-of-Life-A-Randomized-Controlled-Trial-Using-STOPPFrail-Criteria/